Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.

Nora VoggMax KurlbaumTimo DeutschbeinBenedict GräslMartin FassnachtMatthias Kroiss

Published in: Clinical chemistry (2022)

Quantification of dexamethasone and method-specific cortisol cutoffs in DST samples may reduce the false positive rate and lower the proportion of patients requiring further workup.

Keyphrases

low dose
high dose
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors